Comparison Chart Relmada Therapeutics, Inc.
Stocks
RLMD
US75955J4022
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 4.830 USD | -0.41% |
|
+8.05% | - |
| 08-06 | Relmada Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Relmada Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RELMADA THERAPEUTICS, INC. | Bio Therapeutic Drugs | -0.41% | +8.05% | 0.00% | +627.41% | -79.56% | 517M |  |  |  |
- Stock Market
- Stocks
- RLMD Stock
- Charts Relmada Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
